Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 1250.00 | 894.42 | 1969.00 | 2319.50 | 0.8489 | 0.7753 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 8 | 1250.00 | 894.42 | 1868.00 | 2319.50 | 0.8054 | 0.7086 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 1250.00 | 894.42 | 2488.00 | 2319.50 | 1.0726 | 1.1047 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 1250.00 | 894.42 | 1758.00 | 2319.50 | 0.7579 | 0.6348 |
| SK-BR-3 | Lapatinib | 10 | uM | 8 | 1250.00 | 894.42 | 891.00 | 2319.50 | 0.3841 | -0.0028 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 8 | 1250.00 | 894.42 | 2209.00 | 2319.50 | 0.9524 | 0.9302 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 8 | 1250.00 | 894.42 | 2131.00 | 2319.50 | 0.9187 | 0.8804 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 1250.00 | 894.42 | 2467.00 | 2319.50 | 1.0636 | 1.0917 |
| SK-BR-3 | Lapatinib | 1 | uM | 8 | 1250.00 | 894.42 | 1013.00 | 2319.50 | 0.4367 | 0.0948 |
| SK-BR-3 | Linsitinib | 10 | uM | 8 | 1250.00 | 894.42 | 1940.00 | 2319.50 | 0.8364 | 0.7563 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 1250.00 | 894.42 | 2141.00 | 2319.50 | 0.9230 | 0.8868 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 1250.00 | 894.42 | 1216.00 | 2319.50 | 0.5243 | 0.2503 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 8 | 1250.00 | 894.42 | 2598.00 | 2319.50 | 1.1201 | 1.1719 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 8 | 1250.00 | 894.42 | 2477.00 | 2319.50 | 1.0679 | 1.0979 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 8 | 1250.00 | 894.42 | 1393.00 | 2319.50 | 0.6006 | 0.3803 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 8 | 1250.00 | 894.42 | 1014.00 | 2319.50 | 0.4372 | 0.0956 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 8 | 1250.00 | 894.42 | 2292.00 | 2319.50 | 0.9881 | 0.9827 |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 2430.00 | 2319.50 | 1.0476 | 1.0689 | |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 8 | 1250.00 | 894.42 | 2128.00 | 2319.50 | 0.9174 | 0.8785 |
| SK-BR-3 | Linsitinib | 1 | uM | 8 | 1250.00 | 894.42 | 1949.00 | 2319.50 | 0.8403 | 0.7622 |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 2286.00 | 2319.50 | 0.9856 | 0.9790 | |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 2035.00 | 2319.50 | 0.8773 | 0.8184 | |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 2144.00 | 2319.50 | 0.9243 | 0.8888 | |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 1975.00 | 2319.50 | 0.8515 | 0.7793 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 8 | 1250.00 | 894.42 | 1340.00 | 2319.50 | 0.5777 | 0.3419 |